European validation of the Barcelona magnetic resonance predictive model for significant prostate cancer detection in prostate biopsies
Authors:
- Juan MoroteJMJuan Morote
- Berta MiróBMBerta Miró
- Lucas RegisLRLucas Regis
- François CousinFCFrançois Cousin
- Patrick DuflotPDPatrick Duflot
- Philippe KolhPKPhilippe Kolh
- Alice AndalòAAAlice Andalò
- Filippo MerloniFMFilippo Merloni
- Andrea Prochowski IamurriAIAndrea Prochowski Iamurri
- Fabio FerroniFFFabio Ferroni
- Enrique TrillaETEnrique Trilla
Open Access
- 10 April 2026
- journal article
- Published by Wiley in BJUI Compass
- Vol. 7 (4)
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- External validation of the barcelona magnetic resonance imaging predictive model for detecting significant prostate cancer including men receiving 5-alpha reductase inhibitorsWorld Journal of Urology, 2024
- Validation of the Barcelona-MRI predictive model when PI-RADS v2.1 is used with transperineal prostate biopsiesInternational braz j urol, 2024
- Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and futureNature Reviews Urology, 2022
- The Barcelona Predictive Model of Clinically Significant Prostate CancerCancers, 2022
- Decision Curve Analysis: A Novel Method for Evaluating Prediction ModelsMedical Decision Making, 2006